MiNK Therapeutics Inc. Gains 32.95%
Fri, Jan 31, 2025 at 07:36 PM
MiNK Therapeutics Inc. (INKT:NASDAQ) jumped higher at $9.16, representing a gain of 32.9%. On Fri, Jan 31, 2025, INKT:NASDAQ hit a New 2-Week High of $9.16. The stock got featured on our News Catalysts scanner on Thu, Jan 23, 2025 at 03:51 PM in the 'BIOTECH' category. From Tue, Jan 21, 2025, the stock recorded 62.50% Up Days and 55.56% Green Days
About MiNK Therapeutics Inc. (INKT:NASDAQ)
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...
Top 10 Gainers:
- Tarena International Inc. (TCTM:NASDAQ), 329.82%
- Reborn Coffee Inc. (REBN:NASDAQ), 62.56%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 54.33%
- Society Pass Incorporated (SOPA:NASDAQ), 50.5%
- Signing Day Sports Inc. (SGN:NYSEMKT), 47.66%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 45.01%
- F45 Training Holdings Inc. (FXLV:NYSE), 42.86%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 34.95%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 32.95%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 31.02%